EcoDrugPlus

Ensembl ID : ENSCHYG00000009440
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSCHYG00000009426
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSCHYG00000008967
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSCHYG00000008689
Gene Symbol: -
Cross references: -
404 Possible Orthologues:

Ensembl ID : ENSCHYG00000006780
Gene Symbol: -
Cross references: -
401 Possible Orthologues:

Ensembl ID : ENSCHYG00000005385
Gene Symbol: -
Cross references: -
286 Possible Orthologues:

Ensembl ID : ENSCHYG00000005429
Gene Symbol: -
Cross references: -
129 Possible Orthologues:

Ensembl ID : ENSCHYG00000004982
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSCHYG00000004504
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSCHYG00000004161
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSCHYG00000004304
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSCHYG00000004522
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).